These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22889932)

  • 1. Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials.
    Asti M; Atti G; Iori M; Farioli D; Filice A; Versari A
    Nucl Med Commun; 2012 Nov; 33(11):1144-52. PubMed ID: 22889932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labelling of
    Iori M; Capponi PC; Rubagotti S; Esposizione LR; Seemann J; Pitzschler R; Dreger T; Formisano D; Grassi E; Fioroni F; Versari A; Asti M
    Contrast Media Mol Imaging; 2017; 2017():8160134. PubMed ID: 29097938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues.
    Bodei L; Pepe G; Paganelli G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):347-51. PubMed ID: 20496546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions.
    Asti M; Tegoni M; Farioli D; Iori M; Guidotti C; Cutler CS; Mayer P; Versari A; Salvo D
    Nucl Med Biol; 2012 May; 39(4):509-17. PubMed ID: 22172388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personnel exposure in labelling and administration of (177)Lu-DOTA-D-Phe1-Tyr3-octreotide.
    Sghedoni R; Grassi E; Fioroni F; Asti M; Piccagli V; Versari A; Iori M
    Nucl Med Commun; 2011 Oct; 32(10):947-53. PubMed ID: 21876406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin dose saving of the staff in 90Y/177Lu peptide receptor radionuclide therapy with the automatic dose dispenser.
    Fioroni F; Grassi E; Giorgia C; Sara R; Piccagli V; Filice A; Mostacci D; Versari A; Iori M
    Nucl Med Commun; 2016 Oct; 37(10):1046-52. PubMed ID: 27218429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y.
    Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
    Breeman WA; De Jong M; Visser TJ; Erion JL; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):917-20. PubMed ID: 12677301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints.
    Abbasi I; Ishfaq M; Sohaib M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):458-68. PubMed ID: 21068710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy.
    Mukherjee A; Lohar S; Dash A; Sarma HD; Samuel G; Korde A
    J Labelled Comp Radiopharm; 2015 Apr; 58(4):166-72. PubMed ID: 25765604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system.
    Petrik M; Knetsch PA; Knopp R; Imperato G; Ocak M; von Guggenberg E; Haubner R; Silbernagl R; Decristoforo C
    Nucl Med Commun; 2011 Oct; 32(10):887-95. PubMed ID: 21876399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?
    Vallabhajosula S; Kuji I; Hamacher KA; Konishi S; Kostakoglu L; Kothari PA; Milowski MI; Nanus DM; Bander NH; Goldsmith SJ
    J Nucl Med; 2005 Apr; 46(4):634-41. PubMed ID: 15809486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated module radiolabeling of peptides and antibodies with gallium-68, lutetium-177 and iodine-131.
    De Decker M; Turner JH
    Cancer Biother Radiopharm; 2012 Feb; 27(1):72-6. PubMed ID: 22149590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioassay of yttrium-90 radiation using the radionuclide dose calibrator.
    Salako QA; DeNardo SJ
    J Nucl Med; 1997 May; 38(5):723-6. PubMed ID: 9170436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC.
    Di Pierro D; Rizzello A; Cicoria G; Lodi F; Marengo M; Pancaldi D; Trespidi S; Boschi S
    Appl Radiat Isot; 2008 Aug; 66(8):1091-6. PubMed ID: 18226535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro stability of (n,gamma) yttrium-90 hydroxyapatite.
    Khalid M; Mushtaq A
    Appl Radiat Isot; 2005 Apr; 62(4):587-90. PubMed ID: 15701413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
    Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of single-vial ready-for-use formulation of 111In- or 177Lu-labelled somatostatin analogs.
    de Blois E; Chan HS; de Zanger R; Konijnenberg M; Breeman WA
    Appl Radiat Isot; 2014 Feb; 85():28-33. PubMed ID: 24365877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
    Ellison D; Kaufman J; Mather SJ
    Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of radiolysis on yttrium-90-labeled Lym-1 antibody preparations.
    Salako QA; O'Donnell RT; DeNardo SJ
    J Nucl Med; 1998 Apr; 39(4):667-70. PubMed ID: 9544679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.